+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Kinase"

From
From
From
From
From
Janus Kinase (JAK) Inhibitors Global Market Report 2024 - Product Thumbnail Image

Janus Kinase (JAK) Inhibitors Global Market Report 2024

  • Report
  • February 2024
  • 175 Pages
  • Global
From
Tyrosine Kinase Inhibitors: Global Market Outlook - Product Thumbnail Image

Tyrosine Kinase Inhibitors: Global Market Outlook

  • Report
  • November 2023
  • 75 Pages
  • Global
From
Recombinant Proteins Market Report 2023-2033 - Product Thumbnail Image

Recombinant Proteins Market Report 2023-2033

  • Report
  • April 2023
  • 353 Pages
  • Global
From
From
From
From
From
Tyrosine Kinase Inhibitors Global Market Report 2024 - Product Thumbnail Image

Tyrosine Kinase Inhibitors Global Market Report 2024

  • Report
  • February 2024
  • 175 Pages
  • Global
From
Enzyme Inhibitor Global Market Report 2024 - Product Thumbnail Image

Enzyme Inhibitor Global Market Report 2024

  • Report
  • December 2023
  • 200 Pages
  • Global
From
From
From
Loading Indicator

The Kinase market is a subset of the Drug Discovery market, focusing on the development of drugs that target kinases, a type of enzyme that plays a role in many cellular processes. Kinase inhibitors are used to treat a variety of diseases, including cancer, diabetes, and neurological disorders. Kinase inhibitors are typically small molecules that bind to the active site of the kinase, blocking its activity. Kinase inhibitors are developed through a combination of in vitro and in vivo assays, as well as computational modeling. Companies in the Kinase market are focused on developing novel inhibitors that can be used to treat a variety of diseases. These companies include AbbVie, AstraZeneca, Bristol-Myers Squibb, Eli Lilly, GlaxoSmithKline, Merck, Novartis, Pfizer, and Roche. Show Less Read more